176 related articles for article (PubMed ID: 17725338)
1. High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Wan H; Rehngren M; Giordanetto F; Bergström F; Tunek A
J Med Chem; 2007 Sep; 50(19):4606-15. PubMed ID: 17725338
[TBL] [Abstract][Full Text] [Related]
2. High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry.
Wan H; Rehngren M
J Chromatogr A; 2006 Jan; 1102(1-2):125-34. PubMed ID: 16266710
[TBL] [Abstract][Full Text] [Related]
3. Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice.
Maurer TS; Debartolo DB; Tess DA; Scott DO
Drug Metab Dispos; 2005 Jan; 33(1):175-81. PubMed ID: 15502010
[TBL] [Abstract][Full Text] [Related]
4. Brain tissue binding of drugs: evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method.
Longhi R; Corbioli S; Fontana S; Vinco F; Braggio S; Helmdach L; Schiller J; Boriss H
Drug Metab Dispos; 2011 Feb; 39(2):312-21. PubMed ID: 21071520
[TBL] [Abstract][Full Text] [Related]
5. Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Wan H; Ahman M; Holmén AG
J Med Chem; 2009 Mar; 52(6):1693-700. PubMed ID: 19256501
[TBL] [Abstract][Full Text] [Related]
6. Correlation of blood-brain penetration using structural descriptors.
Katritzky AR; Kuanar M; Slavov S; Dobchev DA; Fara DC; Karelson M; Acree WE; Solov'ev VP; Varnek A
Bioorg Med Chem; 2006 Jul; 14(14):4888-917. PubMed ID: 16697202
[TBL] [Abstract][Full Text] [Related]
7. Development of a high-throughput brain slice method for studying drug distribution in the central nervous system.
Fridén M; Ducrozet F; Middleton B; Antonsson M; Bredberg U; Hammarlund-Udenaes M
Drug Metab Dispos; 2009 Jun; 37(6):1226-33. PubMed ID: 19299522
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction.
Summerfield SG; Read K; Begley DJ; Obradovic T; Hidalgo IJ; Coggon S; Lewis AV; Porter RA; Jeffrey P
J Pharmacol Exp Ther; 2007 Jul; 322(1):205-13. PubMed ID: 17405866
[TBL] [Abstract][Full Text] [Related]
9. Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain.
Summerfield SG; Stevens AJ; Cutler L; del Carmen Osuna M; Hammond B; Tang SP; Hersey A; Spalding DJ; Jeffrey P
J Pharmacol Exp Ther; 2006 Mar; 316(3):1282-90. PubMed ID: 16330496
[TBL] [Abstract][Full Text] [Related]
10. Integration of mass spectrometry into early-phase discovery and development of central nervous system agents.
Prokai L; Zharikova A; Janáky T; Li X; Braddy AC; Perjési P; Matveeva L; Powell DH; Prokai-Tatrai K
J Mass Spectrom; 2001 Nov; 36(11):1211-9. PubMed ID: 11747117
[TBL] [Abstract][Full Text] [Related]
11. Unbound brain concentration determines receptor occupancy: a correlation of drug concentration and brain serotonin and dopamine reuptake transporter occupancy for eighteen compounds in rats.
Liu X; Vilenski O; Kwan J; Apparsundaram S; Weikert R
Drug Metab Dispos; 2009 Jul; 37(7):1548-56. PubMed ID: 19389861
[TBL] [Abstract][Full Text] [Related]
12. Estimation of Drug Binding to Brain Tissue: Methodology and in Vivo Application of a Distribution Assay in Brain Polar Lipids.
Belli S; Assmus F; Wagner B; Honer M; Fischer H; Schuler F; Alvarez-Sánchez R
Mol Pharm; 2015 Dec; 12(12):4529-41. PubMed ID: 26560069
[TBL] [Abstract][Full Text] [Related]
13. In silico prediction of central nervous system activity of compounds. Identification of potential pharmacophores by the TOPS-MODE approach.
Cabrera Pérez MA; Sanz MB
Bioorg Med Chem; 2004 Nov; 12(22):5833-43. PubMed ID: 15498659
[TBL] [Abstract][Full Text] [Related]
14. Toward an improved prediction of human in vivo brain penetration.
Summerfield SG; Lucas AJ; Porter RA; Jeffrey P; Gunn RN; Read KR; Stevens AJ; Metcalf AC; Osuna MC; Kilford PJ; Passchier J; Ruffo AD
Xenobiotica; 2008 Dec; 38(12):1518-35. PubMed ID: 18979396
[TBL] [Abstract][Full Text] [Related]
15. Active-site concentrations of chemicals - are they a better predictor of effect than plasma/organ/tissue concentrations?
Hammarlund-Udenaes M
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):215-20. PubMed ID: 20050843
[TBL] [Abstract][Full Text] [Related]
16. Quantitative microdialysis using modified ultraslow microdialysis: direct rapid and reliable determination of free brain concentrations with the MetaQuant technique.
Cremers TI; de Vries MG; Huinink KD; van Loon JP; v d Hart M; Ebert B; Westerink BH; De Lange EC
J Neurosci Methods; 2009 Apr; 178(2):249-54. PubMed ID: 19135084
[TBL] [Abstract][Full Text] [Related]
17. Utility of unbound plasma drug levels and P-glycoprotein transport data in prediction of central nervous system exposure.
He H; Lyons KA; Shen X; Yao Z; Bleasby K; Chan G; Hafey M; Li X; Xu S; Salituro GM; Cohen LH; Tang W
Xenobiotica; 2009 Sep; 39(9):687-93. PubMed ID: 19569734
[TBL] [Abstract][Full Text] [Related]
18. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system.
Feng B; Mills JB; Davidson RE; Mireles RJ; Janiszewski JS; Troutman MD; de Morais SM
Drug Metab Dispos; 2008 Feb; 36(2):268-75. PubMed ID: 17962372
[TBL] [Abstract][Full Text] [Related]
19. Prediction of CNS activity of compound libraries using substructure analysis.
Engkvist O; Wrede P; Rester U
J Chem Inf Comput Sci; 2003; 43(1):155-60. PubMed ID: 12546548
[TBL] [Abstract][Full Text] [Related]
20. Molecular properties determining unbound intracellular and extracellular brain exposure of CNS drug candidates.
Loryan I; Sinha V; Mackie C; Van Peer A; Drinkenburg WH; Vermeulen A; Heald D; Hammarlund-Udenaes M; Wassvik CM
Mol Pharm; 2015 Feb; 12(2):520-32. PubMed ID: 25496026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
